Integrated Diagnostics Holdings PLC Market Cap ($261.60 Million)
Market Cap & Net Worth: Integrated Diagnostics Holdings PLC (IDHC)
Integrated Diagnostics Holdings PLC market cap. Integrated Diagnostics Holdings PLC (LSE:IDHC) has a market capitalization of $261.60 Million ($261.60 Million) as of November 1, 2026. Listed on the LSE stock exchange, this UK-based company holds position #15206 globally and #79 in its home market, demonstrating a -8.16% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integrated Diagnostics Holdings PLC's stock price $0.45 by its total outstanding shares 581326272 (581.33 Million). Also see cash efficiency ratio of Integrated Diagnostics Holdings PLC for how efficiently the company converts equity into cash flow.
Integrated Diagnostics Holdings PLC Market Cap History (2015–2026)
Integrated Diagnostics Holdings PLC market cap history from 2015 to 2026. Data shows change from $503.95 Million to $261.60 Million (-7.38% CAGR). Check IDHC share price today for real-time trading data and today's change.
Integrated Diagnostics Holdings PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Integrated Diagnostics Holdings PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Integrated Diagnostics Holdings PLC net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Integrated Diagnostics Holdings PLC's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.24x
Integrated Diagnostics Holdings PLC's market cap is 0.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $503.95 Million | $1.01 Billion | $144.87 Million | 0.50x | 3.48x |
| 2016 | $348.39 Million | $1.17 Billion | $260.40 Million | 0.30x | 1.34x |
| 2017 | $502.03 Million | $1.51 Billion | $374.02 Million | 0.33x | 1.34x |
| 2018 | $464.94 Million | $1.92 Billion | $502.09 Million | 0.24x | 0.93x |
| 2019 | $463.38 Million | $2.23 Billion | $510.93 Million | 0.21x | 0.91x |
| 2020 | $535.40 Million | $2.66 Billion | $594.01 Million | 0.20x | 0.90x |
| 2021 | $673.29 Million | $5.22 Billion | $1.41 Billion | 0.13x | 0.48x |
| 2022 | $368.56 Million | $3.61 Billion | $541.11 Million | 0.10x | 0.68x |
| 2023 | $206.37 Million | $4.12 Billion | $510.30 Million | 0.05x | 0.40x |
| 2024 | $254.04 Million | $5.72 Billion | $1.08 Billion | 0.04x | 0.24x |
Competitor Companies of IDHC by Market Capitalization
Companies near Integrated Diagnostics Holdings PLC in the global market cap rankings as of November 1, 2026. Also see Integrated Diagnostics Holdings PLC assets under control for a full breakdown of the balance sheet.
Key companies related to Integrated Diagnostics Holdings PLC by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Integrated Diagnostics Holdings PLC (2015–2026)
Market capitalization of Integrated Diagnostics Holdings PLC from 2015 to today. Between 2015 and today, Integrated Diagnostics Holdings PLC's market cap moved from $503.95 Million to $ 261.60 Million, with a yearly change of -7.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $261.60 Million | -39.60% |
| 2025 | $433.09 Million | +70.48% |
| 2024 | $254.04 Million | +23.10% |
| 2023 | $206.37 Million | -44.01% |
| 2022 | $368.56 Million | -45.26% |
| 2021 | $673.29 Million | +25.75% |
| 2020 | $535.40 Million | +15.54% |
| 2019 | $463.38 Million | -0.34% |
| 2018 | $464.94 Million | -7.39% |
| 2017 | $502.03 Million | +44.10% |
| 2016 | $348.39 Million | -30.87% |
| 2015 | $503.95 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Integrated Diagnostics Holdings PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $261.60 Million USD |
| MoneyControl | $261.60 Million USD |
| MarketWatch | $261.60 Million USD |
| marketcap.company | $261.60 Million USD |
| Reuters | $261.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Integrated Diagnostics Holdings PLC
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more